2,5-Dimethoxy-4-bromoamphetamine

DOB
INN: Brolamfetamine
Chemical structure of (±)-DOB
Ball-and-stick model of (R)-DOB
Clinical data
Other namesDOB; 4-Bromo-2,5-dimethoxyamphetamine; Brolamfetamine; Brolamphetamine; Bromo-DMA; 2,5-Dimethoxy-4-bromo-α-methylphenethylamine; 4-Bromo-2,5-dimethoxyphenyl-isopropylamine
Routes of
administration
Oral
Drug classSerotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Legal status
Legal status
  • AU: S9 (Prohibited substance)
  • BR: Class F2 (Prohibited psychotropics)[1]
  • CA: Schedule I
  • UK: Class A
  • US: Schedule I
  • UN: Psychotropic Schedule I
Identifiers
IUPAC name
  • 1-(4-bromo-2,5-dimethoxyphenyl)propan-2-amine
CAS Number
PubChem CID
PubChem SID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H16BrNO2
Molar mass274.158 g·mol−1
3D model (JSmol)
Melting point63–65 °C (145–149 °F)
(207–208 °C hydrochloride)
SMILES
  • CC(CC1=CC(=C(C=C1OC)Br)OC)N
InChI
  • InChI=1S/C11H16BrNO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3 Y
  • Key:FXMWUTGUCAKGQL-UHFFFAOYSA-N Y
  (verify)

Dimethoxybromoamphetamine (DOB), also known as brolamfetamine (INNTooltip International Nonproprietary Name),[2] is a psychedelic drug of the phenethylamine, amphetamine, and DOx families.[3] For many years, prior to the discovery of newer agents such as DOTFM, FLY compounds like Bromo-DragonFLY, and NBOMe compounds like 25I-NBOMe, DOB was the most potent known phenethylamine psychedelic.[3]

The drug acts as an agonist of the serotonin 5-HT2 receptors, including of the serotonin 5-HT2A receptor.[4][5]

DOB was first synthesized by Alexander Shulgin in 1967 and was described by him and his colleagues in the scientific literature in 1971.[6][7] Shulgin subsequently further described the effects of DOB in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).[6]

  1. ^ Anvisa (24 July 2023). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 25 July 2023). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
  2. ^ World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0.
  3. ^ a b Shulgin A (1981). "Profiles of Psychedelic Drugs: 10. DOB". J Psychoactive Drugs. 13 (1): 99. doi:10.1080/02791072.1981.10471457. PMID 7277091.
  4. ^ Cite error: The named reference Ray2010 was invoked but never defined (see the help page).
  5. ^ Cite error: The named reference RudinLuethiHoener2022 was invoked but never defined (see the help page).
  6. ^ a b Erowid Online Books: "PiHKAL" - #62 DOB
  7. ^ Shulgin AT, Sargent T, Naranjo C (1971). "4-Bromo-2,5-dimethoxyphenylisopropylamine, a new centrally active amphetamine analog". Pharmacology. 5 (2): 103–107. doi:10.1159/000136181. PMID 5570923. S2CID 46844380.